000 01509cam  2200337zi 4500
0019.908310
003CaOODSP
00520221107181627
006m     o  d f      
007cr cn|||||||||
008220221t20162016onc     o    f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH164-328/2016E-PDF
24500|aGuidance document : |bNotice of Compliance with conditions (NOC/c).
24630|aNotice of Compliance with conditions (NOC/c)
264 1|aOttawa, ON : |bHealth Canada, Health Products and Food Branch, |c[2016]
264 4|c©2016
300 |a1 online resource (iii, 50 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aCover title.
500 |a"Date adopted : 2002/11/06; revised date : 2016/09/16; effective date : 2016/09/16."
500 |aIssued also in French under title: Ligne directrice : Avis de conformité avec conditions (AC-C).
500 |a"This guidance document combines and supercedes the policy and guidance documents for Notices of Compliance with Conditions (NOC/c) dated June 12, 2007" -- page 1.
650 0|aDrugs|xTesting|xGovernment policy|zCanada.
650 0|aDrugs|xCertification|zCanada.
7101 |aCanada. |bHealth Products and Food Branch, |eissuing body.
77508|tLigne directrice : |w(CaOODSP)9.908309
85640|qPDF|s446 KB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H164-328-2016-eng.pdf